Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 5,577 | 6,692 | 6,473 | 8,348 | 10,795 |
| Cost of Goods | 3,864 | 4,068 | 4,195 | 5,857 | 7,869 |
| Gross Profit | 1,713 | 2,625 | 2,278 | 2,491 | 2,927 |
| Operating Expenses | 4,265 | 3,576 | 4,970 | 7,223 | 10,204 |
| Operating Income | -1,688 | -884 | -2,497 | -3,875 | -6,409 |
| Interest Expense | 39 | 197 | 511 | 633 | 1,878 |
| Other Income | 252 | 2 | -36 | 469 | 1,291 |
| Pre-tax Income | -1,475 | -1,079 | -3,044 | -4,038 | -6,997 |
| Net Income Continuous | -1,475 | -1,079 | -3,044 | -4,038 | -6,997 |
| Net Income | $-1,475 | $-1,079 | $-3,044 | $-4,038 | $-6,997 |
| EPS Basic Total Ops | -0.09 | -0.07 | -0.20 | -0.29 | -0.51 |
| EPS Basic Continuous Ops | -0.08 | -0.06 | -0.19 | -0.27 | -0.49 |
| EPS Diluted Total Ops | -0.09 | -0.07 | -0.20 | -0.29 | -0.51 |
| EPS Diluted Continuous Ops | -0.08 | -0.06 | -0.19 | -0.27 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.07 | -0.17 | -0.25 | N/A |
| EBITDA(a) | $-1,132 | $-216 | $-1,557 | $-2,872 | $-4,864 |